NCT00631410 - Study Of Sunitinib In Combination With Folfox In Patients With Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

March 31, 2010

Conditions

Colorectal Neoplasms

Interventions

DRUG

sunitinib + mFOLFOX6

37.5 mg/day, oral, administered on an outpatient basis for 4 weeks on, 2 weeks off (Schedule 4/2)

DRUG

sunitinib + mFOLFOX6

50 mg/day, oral, administered on an outpatient basis for 2 weeks on, 2 weeks off (Schedule 2/2)

Trial Locations (3)

Pfizer Investigational Site, Kashiwa

Pfizer Investigational Site, Suntougun

Pfizer Investigational Site, Chuo-ku